Notch genes play a central role in both development and disease. Notch proteins are large transmembrane receptors with no apparent enzymatic activity. Although ligands (Serrate) for Notch have been identified, the mechanism of ligand activation and downstream signaling remains poorly understood. Mutations in the Notch signal transduction family are implicated in a number of human disorders. In T-cell Acute Lymphoblastic Leukemia (T-ALL), the Notch 1 locus is involved in a chromosomal translocation with the T-cell recpetor B locus {t(7:9)(q34;q34.3)}. This translocation generates aberrant Notch proteins that lack most of the extracellular sequences. These mutant forms of Notch are thought to be constitutively active; however, the pathophysiological mechanism is unknown. In addition to the involvement of Notch in T-cell leukemia, expression studies have revealed aberrant expression of both Notch and Serrate proteins in other neoplasm including cervical and colorectal carcinoma. The long term goal of this laboratory is to elucidate the mechanisms of Notch signaling in neoplasia. The research proposed in this application is focused on the dissection of the Notch signaling pathway using molecular genetics and biochemistry. Their laboratory has developed an in vitro transformation model for Notch proteins. Activated mutants of Notch that resemble those found in T-ALL are capable of transforming cells in collaboration with E1A. Using this assay, a structure/function analysis will be performed to determine the domains of Notch required for transformation. Other aspects of this work will be directed toward identifying proteins that interact with Notch and determination of the role these proteins play in Notch-mediated transformation. Cellular transformation is a culmination of a number of defects in certain cellular processes, such as apoptosis and cell cycle control. To investigate the role of Notch in such processes a conditionally transforming allele of Notch will be created. A conditional allele of Notch will be useful in studying the early events in neoplastic conversion. Moreover, a conditional allele of Notch will allow us to address the requirement of Notch signaling events in the initiation and maintenance of transformation. The role that Serrate (Notch ligand) plays in activation of Notch and neoplastic transformation will also be studied.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA083736-06
Application #
6796409
Study Section
Pathology B Study Section (PTHB)
Program Officer
Mufson, R Allan
Project Start
2000-09-20
Project End
2006-03-31
Budget Start
2004-09-01
Budget End
2006-03-31
Support Year
6
Fiscal Year
2004
Total Cost
$299,526
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Li, Bin; Orton, Darren; Neitzel, Leif R et al. (2017) Differential abundance of CK1? provides selectivity for pharmacological CK1? activators to target WNT-dependent tumors. Sci Signal 10:
Jin, Ke; Zhou, Wen; Han, Xiaoqing et al. (2017) Acetylation of Mastermind-like 1 by p300 Drives the Recruitment of NACK to Initiate Notch-Dependent Transcription. Cancer Res 77:4228-4237
Han, Xiaoqing; Ranganathan, Prathibha; Tzimas, Christos et al. (2017) Notch Represses Transcription by PRC2 Recruitment to the Ternary Complex. Mol Cancer Res 15:1173-1183
Broadus, Matthew R; Chen, Tony W; Neitzel, Leif R et al. (2016) Identification of a Paralog-Specific Notch1 Intracellular Domain Degron. Cell Rep 15:1920-9
Astudillo, Luisana; Da Silva, Thiago G; Wang, Zhiqiang et al. (2016) The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis. Cancer Res 76:3593-603
Weaver, Kelly L; Alves-Guerra, Marie-Clotilde; Jin, Ke et al. (2014) NACK is an integral component of the Notch transcriptional activation complex and is critical for development and tumorigenesis. Cancer Res 74:4741-51
Bai, Feng; Chan, Ho Lam; Scott, Alexandria et al. (2014) BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Res 74:6161-72
Wang, Zhiqiang; Da Silva, Thiago G; Jin, Ke et al. (2014) Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma. Cancer Res 74:6364-74
Azzam, Diana J; Zhao, Dekuang; Sun, Jun et al. (2013) Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in ?-secretase inhibitor drug responses. EMBO Mol Med 5:1502-22
Licciulli, Silvia; Avila, Jacqueline L; Hanlon, Linda et al. (2013) Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53. Cancer Res 73:5974-84

Showing the most recent 10 out of 26 publications